E2F3 and urinary bladder cancer: Recently, Plk1 has been reported to be regulated by E2F3 transcription factor, a partner of pRb in the regulation of cell cycle transitions, in bladder cancer cells in addition to known E2F3 targets such as Cyclin A [24].